Dolan Sondhi - 21 May 2024 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Director
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
21 May 2024
Net transactions value
$0
Form type
4
Filing time
23 May 2024, 16:52:31 UTC
Previous filing
31 Jul 2023
Next filing
30 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Director Stock Option (right to buy) Award $0 +39,092 $0.000000 39,092 21 May 2024 Common Stock 39,092 $1.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2025 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.